The phrase “science diplomacy” conjured a romantic image: a polar bear standing next to a Russian and an American scientist ...
A phase 2 trial of Enterprise Therapeutics’ cystic fibrosis (CF) drug candidate has hit its primary endpoint, furthering the ...
A doctor by training, Matthew Goodman studied medicine in the UK before specialising in general surgery. He began his career ...
Protein language models are artificial intelligence tools which help engineer proteins with useful properties, including ...
A new sources sought notice targets alternative protein technologies as a means to reduce logistics burdens and strengthen ...
Outraged by the civilian casualties from the war on Iran, protester Guido Reichstadter scaled the 168-foot Frederick Douglass ...
From Genryo’s Sidewinder technology to the Festival of Genomics & Biodata in the UK earlier this year – AI might be trending, ...
BioMADE launches three pilot facilities in California, Iowa and Minnesota with federal funding to address US infrastructure ...
Beyond chronic diseases, CNS drug delivery is also a critical factor in biodefense and national security. As traditional drug-delivery approaches continue to face limitations, alternative methods ...
Advances in artificial intelligence (AI) are transforming the way we analyze, model, and interpret both microbial systems and complex biomedical data.
National Cheng Kung University’s Satoyama Mace Initiative explores "Yellow Carbon" in Tainan, transforming local ...
Breakthroughs in AI drug discovery, in vivo cell therapies, and gene editing are moving rapidly from research into clinical practice, supported by regulatory shifts and renewed investor confidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results